Anne‐Claire Voegeli

1.4k total citations
25 papers, 772 citations indexed

About

Anne‐Claire Voegeli is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Anne‐Claire Voegeli has authored 25 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Anne‐Claire Voegeli's work include Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Research Studies (8 papers) and Colorectal Cancer Treatments and Studies (4 papers). Anne‐Claire Voegeli is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Research Studies (8 papers) and Colorectal Cancer Treatments and Studies (4 papers). Anne‐Claire Voegeli collaborates with scholars based in France, Italy and China. Anne‐Claire Voegeli's co-authors include Michèle Beau‐Faller, Éric Guérin, Gilbert Massard, M Legrain, P Oudet, Erwan Pencreach, Pierre‐Emmanuel Falcoz, Stéphane Renaud, Élisabeth Quoix and Dominique Guénot and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Anne‐Claire Voegeli

24 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne‐Claire Voegeli France 15 462 355 305 155 83 25 772
Kyungsoo Jung South Korea 13 400 0.9× 299 0.8× 224 0.7× 196 1.3× 43 0.5× 20 663
Marco Losa Switzerland 11 242 0.5× 456 1.3× 334 1.1× 154 1.0× 60 0.7× 20 812
A. Kooistra Netherlands 12 576 1.2× 403 1.1× 326 1.1× 198 1.3× 25 0.3× 19 928
Soo Hee Kim South Korea 13 286 0.6× 330 0.9× 207 0.7× 158 1.0× 27 0.3× 37 652
Mitsuru Miyachi Japan 15 297 0.6× 207 0.6× 397 1.3× 251 1.6× 24 0.3× 51 762
Ji Hyun Lee South Korea 12 232 0.5× 269 0.8× 282 0.9× 80 0.5× 46 0.6× 23 609
Vanessa Cerisano Italy 11 318 0.7× 183 0.5× 396 1.3× 163 1.1× 27 0.3× 11 750
Fangchao Zheng China 9 278 0.6× 425 1.2× 272 0.9× 203 1.3× 34 0.4× 33 800
Xinmin Zhao China 13 259 0.6× 354 1.0× 263 0.9× 138 0.9× 23 0.3× 47 666

Countries citing papers authored by Anne‐Claire Voegeli

Since Specialization
Citations

This map shows the geographic impact of Anne‐Claire Voegeli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Claire Voegeli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Claire Voegeli more than expected).

Fields of papers citing papers by Anne‐Claire Voegeli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne‐Claire Voegeli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Claire Voegeli. The network helps show where Anne‐Claire Voegeli may publish in the future.

Co-authorship network of co-authors of Anne‐Claire Voegeli

This figure shows the co-authorship network connecting the top 25 collaborators of Anne‐Claire Voegeli. A scholar is included among the top collaborators of Anne‐Claire Voegeli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne‐Claire Voegeli. Anne‐Claire Voegeli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schneegans, Olivier, et al.. (2025). First Report of SPECC1L::ALK Fusion in Medullary Thyroid Carcinoma with Remarkable Response to Alectinib. Thyroid. 35(6). 701–705. 1 indexed citations
2.
Pencreach, Erwan, Éric Guérin, Valérie Rimelen, et al.. (2022). Direct Targeting KRAS Mutation in Non-Small Cell Lung Cancer: Focus on Resistance. Cancers. 14(5). 1321–1321. 58 indexed citations
3.
Renaud, Stéphane, Francesco Guerrera, Joseph Seitlinger, et al.. (2018). KRAS-specific Amino Acid Substitutions are Associated With Different Responses to Chemotherapy in Advanced Non–small-cell Lung Cancer. Clinical Lung Cancer. 19(6). e919–e931. 14 indexed citations
4.
Renaud, Stéphane, Joseph Seitlinger, Francesco Guerrera, et al.. (2018). Prognostic Value of Exon 19 Versus 21 EGFR Mutations Varies According to Disease Stage in Surgically Resected Non-small Cell Lung Cancer Adenocarcinoma. Annals of Surgical Oncology. 25(4). 1069–1078. 13 indexed citations
5.
Guérin, Éric, et al.. (2017). A compound heterozygote case of isolated sulfite oxidase deficiency. Molecular Genetics and Metabolism Reports. 12. 99–102. 5 indexed citations
6.
Italiano, Antoîne, Gaëlle Pierron, Nathalie Auger, et al.. (2016). Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study. The Lancet Oncology. 17(4). 532–538. 118 indexed citations
7.
Guerrera, Francesco, Stéphane Renaud, Fabrizio Tabbò, et al.. (2016). Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomas†. European Journal of Cardio-Thoracic Surgery. 51(4). 680–688. 15 indexed citations
8.
Renaud, Stéphane, Joseph Seitlinger, Pierre‐Emmanuel Falcoz, et al.. (2016). Specific KRAS amino acid substitutions and EGFR mutations predict site-specific recurrence and metastasis following non-small-cell lung cancer surgery. British Journal of Cancer. 115(3). 346–353. 51 indexed citations
9.
Seitlinger, Joseph, Stéphane Renaud, Pierre‐Emmanuel Falcoz, et al.. (2016). Epidermal growth factor receptor and v-Ki-ras2 Kirsten rat sarcoma viral oncogen homologue-specific amino acid substitutions are associated with different histopathological prognostic factors in resected non-small-cell lung cancer. Interactive Cardiovascular and Thoracic Surgery. 23(6). 902–907. 2 indexed citations
10.
Renaud, Stéphane, Mickaël Schaeffer, Pierre‐Emmanuel Falcoz, et al.. (2016). Perioperative bevacizumab improves survival following lung metastasectomy for colorectal cancer in patients harbouringv-Ki-ras2 Kirsten rat sarcoma viral oncogene homologueexon 2 codon 12 mutations†. European Journal of Cardio-Thoracic Surgery. 51(2). ezw304–ezw304. 10 indexed citations
11.
Beau‐Faller, Michèle, Stéphane Renaud, Noëlle Weingertner, et al.. (2015). Carcinomes bronchiques non à petites cellules (CBNPC) métastatiques, mutés ou réarrangés : comment déterminer la cible ?. Revue des Maladies Respiratoires Actualités. 7(4). 476–496.
12.
Renaud, Stéphane, Pierre‐Emmanuel Falcoz, Mickaël Schaeffer, et al.. (2015). Prognostic value of the KRAS G12V mutation in 841 surgically resected Caucasian lung adenocarcinoma cases. British Journal of Cancer. 113(8). 1206–1215. 56 indexed citations
13.
Weingertner, Noëlle, Nicolás Meyer, Anne‐Claire Voegeli, et al.. (2015). Correlation between MET protein expression and MET gene copy number in a Caucasian cohort of non-small cell lung cancers according to the new IASLC/ATS/ERS classification. Pathology. 47(4). 320–328. 16 indexed citations
14.
Baffert, Sandrine, Antoîne Italiano, Gaëlle Pierron, et al.. (2013). Analyse comparative des coûts de techniques de biologie moléculaire dans le diagnostic de sarcomes. Bulletin du Cancer. 100(10). 963–971. 1 indexed citations
15.
Beau‐Faller, Michèle, Nathalie Prim, Anne-Marie Ruppert, et al.. (2012). Rare epidermal growth factor receptor (EGFR) mutations in 10,117 patients with non-small cell lung cancer (NSCLC) evaluated by the French ERMETIC IFCT network: Clinical, molecular, and survival data.. Journal of Clinical Oncology. 30(15_suppl). 10507–10507. 5 indexed citations
16.
17.
Chamouard, Patrick, Fanny Monneaux, Anne‐Claire Voegeli, et al.. (2008). Diminution of Circulating CD4+CD25high T Cells in Naïve Crohn’s Disease. Digestive Diseases and Sciences. 54(10). 2084–2093. 22 indexed citations
18.
Beau‐Faller, Michèle, Anne-Marie Ruppert, Anne‐Claire Voegeli, et al.. (2008). MET Gene Copy Number in Non-small Cell Lung Cancer: Molecular Analysis in a Targeted Tyrosine Kinase Inhibitor Naïve Cohort. Journal of Thoracic Oncology. 3(4). 331–339. 162 indexed citations
19.
Zhang, Dan, Thomas Lavaux, Anne‐Claire Voegeli, et al.. (2008). Prognostic Value of Chromogranin A at Admission in Critically Ill Patients: A Cohort Study in a Medical Intensive Care Unit. Clinical Chemistry. 54(9). 1497–1503. 37 indexed citations
20.
Voegeli, Anne‐Claire, Alice Meyer, Marie‐Pierre Gaub, et al.. (2001). Coexistence of the methylene tetrahydrofolate reductase (MTHFR) Cs77T, the factor II G20210A and the factor V Leiden mutations in idiopathic portal vein thrombosis. Gastroenterology. 120(5). A196–A196. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyungsoo Jung Breakdown of academic impact, for papers by Marco Losa Breakdown of academic impact, for papers by A. Kooistra Breakdown of academic impact, for papers by Soo Hee Kim Breakdown of academic impact, for papers by Mitsuru Miyachi Breakdown of academic impact, for papers by Ji Hyun Lee Breakdown of academic impact, for papers by Vanessa Cerisano Breakdown of academic impact, for papers by Fangchao Zheng Breakdown of academic impact, for papers by Xinmin Zhao
Rankless by CCL
2026